FUT11: A Drug Target / Disease Biomarker (G170384)
FUT11: A Drug Target / Disease Biomarker
FUT11 is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a key regulator of cell growth and differentiation, and is involved in many important cellular processes that are necessary for human health and development.
Recent studies have identified FUT11 as a potential drug target for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This is because FUT11 is involved in many cellular processes that are disrupted in these conditions, and because it is a protein that is expressed in a wide range of tissues.
One of the key reasons why FUT11 is a promising drug target is that it is highly conserved across many different species. This means that it is unlikely to have a significant impact on the structure and function of the protein in different organisms, which could make it easier to develop a drug that works in humans.
Another reason why FUT11 is a promising drug target is that it is involved in many important cellular processes that are necessary for human health and development. For example, FUT11 is involved in the regulation of cell growth and differentiation, which are important for the development and maintenance of tissues throughout the body. It is also involved in the regulation of cell death, which is important for the removal of damaged or dysfunctional cells.
In addition, FUT11 is involved in the regulation of many different signaling pathways that are important for human health and development. For example, it is involved in the signaling pathway that regulates cell proliferation, and it is also involved in the signaling pathway that regulates the development and progression of cancer.
Overall, FUT11 is a protein that is involved in many important cellular processes that are necessary for human health and development. As a result, it is a promising drug target for a variety of diseases. Further research is needed to determine the full extent of FUT11's role in these conditions, and to develop effective treatments that target this protein.
Protein Name: Fucosyltransferase 11
Functions: Has minor fucosyltransferase activity toward biantennary N-glycan acceptors. Does not fucosylate GlcNAc residue within type 2 lactosamine unit
More Common Targets
FUT2 | FUT3 | FUT4 | FUT5 | FUT6 | FUT7 | FUT8 | FUT8-AS1 | FUT9 | FUZ | FXN | FXR1 | FXR2 | FXYD1 | FXYD2 | FXYD3 | FXYD4 | FXYD5 | FXYD6 | FXYD6-FXYD2 | FXYD7 | FYB1 | FYB2 | FYCO1 | FYN | FYTTD1 | FZD1 | FZD10 | FZD10-AS1 | FZD2 | FZD3 | FZD4 | FZD4-DT | FZD5 | FZD6 | FZD7 | FZD8 | FZD9 | FZR1 | G protein-Coupled Inwardly-Rectifying Potassium Channel (GIRK) | G Protein-Coupled Receptor Kinases (GRKs) | G0S2 | G2E3 | G2E3-AS1 | G3BP1 | G3BP2 | G6PC1 | G6PC2 | G6PC3 | G6PD | GA-binding protein | GAA | GAB1 | GAB2 | GAB3 | GAB4 | GABA(A) receptor | GABARAP | GABARAPL1 | GABARAPL2 | GABARAPL3 | GABBR1 | GABBR2 | GABPA | GABPAP | GABPB1 | GABPB1-AS1 | GABPB1-IT1 | GABPB2 | GABRA1 | GABRA2 | GABRA3 | GABRA4 | GABRA5 | GABRA6 | GABRB1 | GABRB2 | GABRB3 | GABRD | GABRE | GABRG1 | GABRG2 | GABRG3 | GABRG3-AS1 | GABRP | GABRQ | GABRR1 | GABRR2 | GABRR3 | GACAT1 | GACAT2 | GACAT3 | GAD1 | GAD2 | GADD45A | GADD45B | GADD45G | GADD45GIP1 | GADL1 | GAGE1